USANA Health Sciences, Inc. (USNA) のトレーリングPERは 30.1, 予想PER 10.9. トレーリング益回りは 3.32%, 予想益回り 9.21%. PEG 0.05 (Peter Lynch 割安基準 ≤1.0). グレアム数は $20.58.
このページで証明された基準:
SharesGrow 総合スコア： 64/100 3/7 項目が合格。
| Year | P/E (TTM) | PEG レシオ | P/B レシオ | P/S レシオ | 配当利回り |
|---|---|---|---|---|---|
| 2016 | 15.0 | 1.46 | 4.61 | 1.49 | - |
| 2017 | 28.4 | -0.78 | 4.90 | 1.70 | - |
| 2018 | 22.0 | 0.21 | 7.09 | 2.33 | - |
| 2019 | 17.7 | -1.03 | 5.06 | 1.68 | - |
| 2020 | 13.0 | 0.40 | 3.67 | 1.43 | - |
| 2021 | 17.5 | -9.37 | 5.16 | 1.72 | - |
| 2022 | 14.8 | -0.39 | 2.36 | 1.03 | - |
| 2023 | 16.2 | -2.16 | 2.08 | 1.12 | - |
| 2024 | 16.2 | -0.48 | 1.28 | 0.80 | - |
| 2026 | 33.6 | -0.46 | 0.68 | 0.39 | - |
| Year | EPS（希薄化後） | 売上高 | 純利益 | 純利益率 |
|---|---|---|---|---|
| 2019 | $4.41 | $1.06B | $100.53M | 9.5% |
| 2020 | $5.86 | $1.13B | $124.66M | 11% |
| 2020 | $5.86 | $1.13B | $124.66M | 11% |
| 2021 | $5.73 | $1.19B | $116.51M | 9.8% |
| 2021 | $5.73 | $1.19B | $116.51M | 9.8% |
| 2022 | $3.59 | $998.6M | $69.35M | 6.9% |
| 2023 | $3.30 | $921.01M | $63.79M | 6.9% |
| 2023 | $3.30 | $921.01M | $63.79M | 6.9% |
| 2024 | $2.19 | $854.5M | $42.03M | 4.9% |
| 2025 | $0.58 | $925.26M | $10.76M | 1.2% |
| Year | EPS（平均） | EPS レンジ | 売上高（平均） | 売上高レンジ | アナリスト数 |
|---|---|---|---|---|---|
| 2026 | $1.74 | $1.74 – $1.74 | $925.02M | $925.02M – $925.02M | 1 |
| 2027 | $2.00 | $2.00 – $2.00 | $942.45M | $942.45M – $942.45M | 1 |
| 2028 | $2.77 | $2.77 – $2.77 | $1B | $1B – $1B | 1 |
